Evidence map›Paper›PMID 33280073›Full record

ArticleHealth economics review2020

Comparison of the cost of illness of primary liver cancer between Japan and Taiwan.

Yinghui Wu, Kunichika Matsumoto, Ya-Mei Chen, Yu-Chi Tung, Tzu-Ying Chiu, Tomonori Hasegawa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health economics review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Yinghui WuSchool of Nursing, Shanghai Jiao Tong University, Shanghai, China.
Kunichika MatsumotoDepartment of Social Medicine, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-ku, Tokyo, 143-8540, Japan.
Ya-Mei ChenInstitute of Health Policy & Management, College of Public Health, National Taiwan University, Taipei, Taiwan.
Yu-Chi TungInstitute of Health Policy & Management, College of Public Health, National Taiwan University, Taipei, Taiwan.
Tzu-Ying ChiuGraduate Institute of Long-term Care, Tzu Chi University of Science and Technology, Hualien, Taiwan.
Tomonori HasegawaDepartment of Social Medicine, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-ku, Tokyo, 143-8540, Japan. tommie@med.toho-u.ac.jp.ORCID http://orcid.org/0000-0002-1057-9867
National Taiwan University · TWToho University · JPShanghai Jiao Tong University · CNTzu Chi University · TW

Funding

Shanghai Municipal Education Commission-Nursing Gaoyuan Project hlgy16053kyggShanghai Municipal Health and Family Planning Commission 201640176
6 · The paper itself

Abstract

backgroundPrimary liver cancer (PLC) is the fifth and second leading cause of death in Japan and Taiwan, respectively. The aim of this study was to compare the economic burden of PLC between the two countries using the cost of illness (COI) method and identify the key factors causing the different trends in the economic burdens of PLC. MATERIALS AND

methodsWe calculated the COI every 3 years using governmental statistics of both countries (1996-2014 data for Japan and 2002-2014 data for Taiwan). The COI was calculated by summing the direct costs, morbidity costs, and mortality costs. We compared the COIs of PLC in both countries at the USD-based cost. The average exchange rate during the targeted years was used to remove the impact of foreign exchange volatility.

resultsFrom 1996 to 2014, the COI exhibited downward and upward trends in Japan and Taiwan, respectively. In Japan, the COI in 2014 was 0.70 times the value in 1996, and in Taiwan, the COI in 2014 was 1.16 times greater than that in 1996. The mortality cost was the greatest contributor in both countries and had the largest contribution ratio to the COI increase in Japan. However, the direct cost in Taiwan had the largest contribution ratio to the COI decrease.

conclusionsTo date, the COI of PLC in Japan has continuously decreased, whereas that in Taiwan has increased. Previous health policies and technological developments are thought to have accelerated the COI decrease in Japan and are expected to change the trend of COI of PLC, even in Taiwan.

Indexed as

Cost of illnessHealth policyLiver neoplasmsMedical economicsPublic health

Identifiers

PMID33280073
PMCPMC7719254
OpenAlexW3111449334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.